I don't like doing this, but it is necessary to identify the US taxpayer-funded scientists involved in the ongoing atrocity of fetal organ-implanted humanized mice production. I pray for these people every day that their hearts will be changed, and that they will stop exploiting tiny humans for the sake of biomedical technological advances.
Ralph Baric, PhD, Professor in the Department of Microbiology and Immunology at The University of North Carolina at Chapel Hill. He and his UNC team created the HFH4-FoxJ-hACE2 mice humanized with fetal tissue-derived fetal clone serum and the FOXj4 antibody in 2015 for use in making wild bat coronavirus transmissible to humans. Also developed the LoM and BLT-L precision mice models in 2019.
Angela Wahl, PhD, Research Instructor in the Institute for Global Health and Infectious Diseases and the Center for AIDS Research at the University of North Carolina at Chapel Hill. Primary researcher involved in the 2019 NIH-funded study which developed the LoM (lung-only mice) and BLT-L (bone marrow, liver, thymus and lung) mice models for coronavirus vaccine testing. LoM mice are immunodeficient mice with engrafted patches of human fetal lung tissue their backs. BLT-L mice are implanted with a "sandwich" of human fetal liver and thymus and human fetal lung patches and CD34+ cells extracted from human fetal liver injected in the tail. (Fetal liver, thymus and lung tissue for this study obtained from Advanced Bioscience Resources.) They are the most humanized mice models with fully human immune systems and human lung tissue ideal for vaccine testing. Dr. Wahl also conducted two studies on the COVID-19 pill, Molnupiravir, with her LoM mice models. Dr. Tara Sander Lee of Charlotte Lozier Institute has documented that twelve aborted babies were sacrificed for use in the 2021 study. Dr. Wahl also conducted a similar study using aborted baby lung tissue obtained from Advanced Bioscience Resources in 2020.
Lisa Gralinski, PhD, Assistant Professor, Department of Epidemiology, at the University of North Carolina at Chapel Hill. Co-authored the 2021 and 2020 studies testing Molnupiravir with LoM mice models, engrafted with human fetal lung tissue cited above. Prominent advocate of Faucian propaganda on Twitter.
Kim Hasenkrug, PhD, Chief, Retroviral Immunology Section at NIH Rocky Mountain Laboratories, Hamilton, MT. Exposed by Judicial Watch as having purchased thousands of dollars' worth of aborted baby organs for BLT mice development for HIV research from Advanced Bioscience Resources. In March, 2020, he made headlines for demanding that Trump Administration's ban on fetal research be lifted so he could make Ralph Baric's BLT-L (engrafted with human fetal liver, thymus and lung) mice for COVID-19 research.
Kerry Lavender, PhD, Assistant Professor Biochemistry, Microbiology & Immunology, at the University of Saskatchewan. Dr. Lavender worked for many years at the NIH Rocky Mountain Lab with Kim Hasenkrug and Ronald Messer. Dr. Lavender co-authored several key studies on BLT mice which involved the use of aborted baby liver and thymus obtained from ABR. She has claimed credit for developing a special strain of black mice known as the TKO-BLT. UNC researchers offered Hasenkrug three dozen BLT-L mice produced in the 2019 Wahl et al. study for COVID-19 research. Because of the Trump Administration's ban on fetal research, Dr. Lavender took the mice to the University of Saskatchewan in Saskatoon, Canada, where she is making a continuous supply of hundreds of BLT-L mice for COVID-19 vaccine research.
Darryl Falzarano, PhD, Research Scientist at VIDO-InterVac, an international research center in Saskatoon. Dr. Falzarano completed his postdoctoral studies at NIH Rocky Mountain Lab in Hamilton, MT and co-authored several studies with Dr. Angela Rasmussen (see below). He is noted as the inventor of a MERS vaccine for camels and is currently collaborating with former NIH Researcher Kerry Lavender on a multi-million dollar project developing a pan-coronavirus vaccine for humans. using the BLT-L humanized mouse.
Angela Rasmussen, PhD, worked as Principal Investigator for (DARPA), Lead scientist on contracts for the Defense Threat Reduction Agency (DTRA), and the National Biodefense and Countermeasures Center (NBACC), also worked as a special volunteer at the Rocky Mountain Laboratories Integrated Research Facility. She left Columbia University's Center of Infection and Immunity (CII) last December and is currently employed as a Research Scientist III at VIDO-InterVac in Saskatoon.
Megan Sykes, PhD, Director of the Columbia Center for Translational Immunology. Dr. Sykes has worked extensively with HIS (human immune system) mice. She has co-authored many NIH-funded studies on BLT mice involving fetal human liver and thymus obtained from ABR. Twelve of these studies published on the NIH website can be found here. Her department currently offers HIS mice humanized with human fetal thymus for COVID-19 research on the Columbia University website.
Yong-Guang Yang, is a researcher affiliated with Columbia University and the Laboratory of Organ Regeneration and Transplantation of The First Hospital of Jilin University, China.
Yong-Guang Yang was awarded $6.6 million in NIH funding from 2006 to 2016. A look at several of Yang's projects entitled "Small Animal Core"conducted at Columbia University and Massachusetts General Hospital reveals that he was making humanized mice with human fetal thymus tissue. Further investigation reveals many more NIH-funded studies in which both Yong-Guang Yang and Megan Sykes collaborated, which also involved the use of fetal liver and thymus, often noted as being obtained from Advanced Bioscience Resources. His latest published study is dated November, 2021, and is entitled, "Scrutiny of human lung infection by SARS-CoV-2 and associated human immune responses in humanized mice." The full text is not available yet, but the Abstract notes that the humanized mice are engrafted with human lung tissue.
*The next person is not an NIH-funded researcher, but a person of interest because of the ubiquitousness of the Regeneron monoclonal antibody cocktail. Regeneron has a history of using fetal human organs obtained from ABR to humanize their mice.
George D. Yancopoulos, co-founder, president and chief scientific officer of Regeneron Pharmaceuticals. He co-authored two studies conducted by Regeneron scientists in 2011 and 2017 using human fetal liver obtained from the ABR to humanize mice. One study involved "at least 20 samples, which may mean that at least 20 aborted babies were used. Another Regeneron-affiliated study was conducted at Yale in March 2021 to make a MSTRG6 humanized mouse which required the use of human fetal liver. This mouse model was designed for the testing of monoclonal antibodies. These studies involving human fetal liver were prerequisite research for the development of the REGN-COV2 monoclonal antibody cocktail.
If I find any more significant figures involved in the use of fetal organs for COVID-19 humanized mice studies, I will add them to the list. I urge you to pray for these individuals above that they use their considerable talents and knowledge in research that does not require the sacrifice of human babies and the cruel exploitation and genetic re-engineering of God's creatures.